Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AdaptHealth (AHCO) Cost of Revenue (2019 - 2025)

Historic Cost of Revenue for AdaptHealth (AHCO) over the last 7 years, with Q3 2025 value amounting to $658.4 million.

  • AdaptHealth's Cost of Revenue rose 226.42% to $658.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 billion, marking a year-over-year increase of 634.55%. This contributed to the annual value of $2.6 billion for FY2024, which is 14.64% up from last year.
  • Latest data reveals that AdaptHealth reported Cost of Revenue of $658.4 million as of Q3 2025, which was up 226.42% from $645.7 million recorded in Q2 2025.
  • In the past 5 years, AdaptHealth's Cost of Revenue registered a high of $693.5 million during Q3 2023, and its lowest value of $396.7 million during Q1 2021.
  • Moreover, its 5-year median value for Cost of Revenue was $636.6 million (2024), whereas its average is $606.2 million.
  • Its Cost of Revenue has fluctuated over the past 5 years, first soared by 14731.63% in 2021, then crashed by 929.43% in 2022.
  • Quarter analysis of 5 years shows AdaptHealth's Cost of Revenue stood at $591.6 million in 2021, then decreased by 9.29% to $536.6 million in 2022, then rose by 3.2% to $553.8 million in 2023, then rose by 19.97% to $664.4 million in 2024, then decreased by 0.91% to $658.4 million in 2025.
  • Its Cost of Revenue was $658.4 million in Q3 2025, compared to $645.7 million in Q2 2025 and $657.4 million in Q1 2025.